Aclaris Therapeutics Inc —— 资产负债表 (NASDAQ:ACRS) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 70.78 M251.21 M254.6 M197.41 M220.33 M160.46 M 负债总额 33.13 M53.87 M56.98 M40.23 M64.77 M57.38 M 权益总额 37.65 M197.34 M197.62 M157.18 M155.55 M103.08 M 负债及股东权益总额 70.78 M251.21 M254.6 M197.41 M220.33 M160.46 M 总债务 14.15 M13.55 M———— 净债务 -39.95 M-212.15 M————

新闻

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

H.C. Wainwright维持Aclaris Therapeutics买入评级

Aclaris Therapeutics stock rating reiterated at Buy by H.C. Wainwright

Stifel因管线前景上调Aclaris Therapeutics目标价至3美元

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Aclaris TherapeuticsQ4每股收益及营收逊于预期

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates

Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates

Aclaris启动ATI-052治疗哮喘患者的1b期试验

Aclaris starts phase 1b trial of ATI-052 in asthma patients